Inhaler Devices Still a Major Hurdle in Asthma/Copd Inhaler Devices Still a Major Hurdle in Asthma/Copd

Inhaler Devices Still a Major Hurdle in Asthma/Copd

Worldwide Biotech 2008, July 1, 20, 7

    • ‏5٫99 US$
    • ‏5٫99 US$

وصف الناشر

Although the inhaled delivery of drugs has major advantages over other methods of administration, inhaler devices are often difficult to use and can indirectly have a negative impact on symptom control. Unfortunately, in a classic catch-22 situation, those devices that are developed to overcome the disadvantages of the majority of inhalers often lack broad availability across different therapeutic molecules and drug classes. Offering physicians and patients a range of therapies in the same type of device will therefore improve proper use of inhalers, which can indirectly have a positive impact on the control of diseases like asthma and chronic obstructive pulmonary disease (COPD), according to a new report* by independent market analyst Datamonitor. Benefits of inhalers obvious

النوع
تمويل شركات وأفراد
تاريخ النشر
٢٠٠٨
١ يوليو
اللغة
EN
الإنجليزية
عدد الصفحات
٥
الناشر
Worldwide Videotex
البائع
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
الحجم
٥٣٫٦
ك.ب.
Living With Your Heart & Lungs Living With Your Heart & Lungs
٢٠١١
Effective Natural Remedies for Idiopathic Pulmonary Fibrosis Effective Natural Remedies for Idiopathic Pulmonary Fibrosis
٢٠١٣
Essential Aspects of Aeromedical Retrieval Essential Aspects of Aeromedical Retrieval
٢٠١٢
Basics of Pediatric Anesthesia Basics of Pediatric Anesthesia
٢٠١٦
Avita Gets AU$2M from US Military to Speed Device Approval Avita Gets AU$2M from US Military to Speed Device Approval
٢٠٠٩
UCB Launches Cimplicity to Enhance Treatment Support for Cimzia UCB Launches Cimplicity to Enhance Treatment Support for Cimzia
٢٠٠٨
Subjects Enrolled in Presept Colorectal Cancer Screening Subjects Enrolled in Presept Colorectal Cancer Screening
٢٠٠٨
Is Cost Containment Impacting Pharmaceutical Innovation? Is Cost Containment Impacting Pharmaceutical Innovation?
٢٠٠٨
Methylgene to Resume Development of MGCD0103 (Mocetinostat) Methylgene to Resume Development of MGCD0103 (Mocetinostat)
٢٠٠٩
Intercell Outlicenses Group B Streptococcus Vaccine Intercell Outlicenses Group B Streptococcus Vaccine
٢٠٠٩